Acute hyperglycemia state is associated with lower tPA-induced recanalization rates in stroke patients - PubMed (original) (raw)
Acute hyperglycemia state is associated with lower tPA-induced recanalization rates in stroke patients
Marc Ribo et al. Stroke. 2005 Aug.
Abstract
Background and purpose: Hyperglycemia (HG) has a deleterious effect in stroke patients by accelerating ischemic brain damage; moreover, its antifibrinolytic effect may also influence reperfusion. We aimed to study the effect of acute/chronic HG on tissue-type plasminogen activator (tPA)-induced recanalization.
Methods: We studied 139 consecutive stroke patients with documented intracranial artery occlusion treated with intravenous tissue-type plasminogen activator (tPA). Admission glucose levels were recorded (in mg/dL). The existence of previous chronic HG was determined by plasma levels of glycosylated hemoglobin (HbA1c, %) and fructosamine (in micromol/L). Transcranial Doppler monitoring assessed complete recanalization 2 hours after tPA bolus. National Institutes of Health Stroke Scale (NIHSS) scores were obtained at baseline and 48 hours.
Results: On admission, the median NIHSS score was 18 and mean glucose value was 140+/-63 mg/dL. At 2 hours, 32% of patients(n=44) achieved complete recanalization. Patients who recanalized showed lower admission glucose levels (127 vs 146 mg/dL; P=0.039) but no differences in HbA1c (6.3% vs 6.3%; P=0.896) or fructosamine (292 vs 293 micromol/L; P=0.957) were observed. Other variables associated with recanalization were initial distal middle cerebral artery occlusion (P=0.011) and platelet count (P=0.015). Patients with an admission glucose level >158 mg/dL had lower recanalization rates (16% vs 36.1%; P=0.035) and a higher NIHSS score at 48 hours (7 vs 14.5; P=0.04). After adjustment for stroke etiology, age, and risk factors, the only independent predictors on admission of no recanalization were glucose value >158 mg/dL (odds ratio [OR], 7.3; 95% confidence interval [CI], 1.3 to 42.3; P=0.027), proximal middle cerebral artery occlusion (OR, 2.6; 95% CI, 1.1 to 6.5; P=0.034), and platelet count <219,000/mL (OR, 2.6; 95% CI, 1.1 to 6.1; P=0.029).
Conclusions: In tPA-treated patients, the acute but not chronic HG state may hamper the fibrinolytic process, delaying reperfusion of the ischemic penumbra. Early measures to reduce HG may favor early recanalization.
Similar articles
- Effects of admission hyperglycemia on stroke outcome in reperfused tissue plasminogen activator--treated patients.
Alvarez-Sabín J, Molina CA, Montaner J, Arenillas JF, Huertas R, Ribo M, Codina A, Quintana M. Alvarez-Sabín J, et al. Stroke. 2003 May;34(5):1235-41. doi: 10.1161/01.STR.0000068406.30514.31. Epub 2003 Apr 3. Stroke. 2003. PMID: 12677014 - Impact of admission hyperglycemia on stroke outcome after thrombolysis: risk stratification in relation to time to reperfusion.
Alvarez-Sabín J, Molina CA, Ribó M, Arenillas JF, Montaner J, Huertas R, Santamarina E, Rubiera M. Alvarez-Sabín J, et al. Stroke. 2004 Nov;35(11):2493-8. doi: 10.1161/01.STR.0000143728.45516.c6. Epub 2004 Oct 7. Stroke. 2004. PMID: 15472110 - The correlation between admission blood glucose and intravenous rt-PA-induced arterial recanalization in acute ischemic stroke: a multi-centre TCD study.
Saqqur M, Shuaib A, Alexandrov AV, Sebastian J, Khan K, Uchino K. Saqqur M, et al. Int J Stroke. 2015 Oct;10(7):1087-92. doi: 10.1111/ijs.12517. Epub 2015 Sep 1. Int J Stroke. 2015. PMID: 26332252 Clinical Trial. - Is the benefit of early recanalization sustained at 3 months? A prospective cohort study.
Labiche LA, Al-Senani F, Wojner AW, Grotta JC, Malkoff M, Alexandrov AV. Labiche LA, et al. Stroke. 2003 Mar;34(3):695-8. doi: 10.1161/01.STR.0000055940.00316.6B. Epub 2003 Feb 13. Stroke. 2003. PMID: 12624293 Clinical Trial. - [Acute hyperglycemia and reperfusion therapy in stroke patients].
Krajícková D. Krajícková D. Vnitr Lek. 2010 Apr;56(4):295-300. Vnitr Lek. 2010. PMID: 20465099 Review. Czech.
Cited by
- Personalized Consideration of Admission-Glucose Gap between Estimated Average and Initial Glucose Levels on Short-Term Stroke Outcome.
Kim Y, Lee SH, Kim C, Kang MK, Yoon BW, Kim TJ, Bae JS, Lee JH. Kim Y, et al. J Pers Med. 2021 Feb 18;11(2):139. doi: 10.3390/jpm11020139. J Pers Med. 2021. PMID: 33670504 Free PMC article. - Intensive vs Standard Treatment of Hyperglycemia and Functional Outcome in Patients With Acute Ischemic Stroke: The SHINE Randomized Clinical Trial.
Johnston KC, Bruno A, Pauls Q, Hall CE, Barrett KM, Barsan W, Fansler A, Van de Bruinhorst K, Janis S, Durkalski-Mauldin VL; Neurological Emergencies Treatment Trials Network and the SHINE Trial Investigators. Johnston KC, et al. JAMA. 2019 Jul 23;322(4):326-335. doi: 10.1001/jama.2019.9346. JAMA. 2019. PMID: 31334795 Free PMC article. Clinical Trial. - Clinical Implications of Serial Glucose Measurements in Acute Ischemic Stroke Patients Treated with Intravenous Thrombolysis.
Kim JT, Lee SY, Yoo DS, Lee JS, Kim SH, Choi KH, Park MS, Cho KH. Kim JT, et al. Sci Rep. 2018 Aug 6;8(1):11761. doi: 10.1038/s41598-018-30028-1. Sci Rep. 2018. PMID: 30082824 Free PMC article. - Predictive Modeling of Short-Term Poor Prognosis of Successful Reperfusion after Endovascular Treatment in Patients with Anterior Circulation Acute Ischemic Stroke.
Zhang Z, Song C, Zhang L, Yang W. Zhang Z, et al. J Healthc Eng. 2022 Aug 12;2022:3185211. doi: 10.1155/2022/3185211. eCollection 2022. J Healthc Eng. 2022. PMID: 35991294 Free PMC article. - Effect of Collaterals on Clinical Presentation, Baseline Imaging, Complications, and Outcome in Acute Stroke.
Fanou EM, Knight J, Aviv RI, Hojjat SP, Symons SP, Zhang L, Wintermark M. Fanou EM, et al. AJNR Am J Neuroradiol. 2015 Dec;36(12):2285-91. doi: 10.3174/ajnr.A4453. Epub 2015 Oct 15. AJNR Am J Neuroradiol. 2015. PMID: 26471754 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical